𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of hepatitis B surface antigen mutations in Mongolia: Molecular epidemiology and implications for mass vaccination

✍ Scribed by D. Davaalkham; T. Ojima; R. Uehara; M. Watanabe; I. Oki; K. Endo; M. Takahashi; H. Okamoto; Y. Nakamura


Book ID
106210741
Publisher
Springer Vienna
Year
2006
Tongue
English
Weight
404 KB
Volume
152
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A molecular analysis of viral persistenc
✍ J Kato; K Hasegawa; N Torii; K Yamauchi; N Hayashi πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 683 KB

To identify the mechanisms of viral persistence in coincides with the cessation of hepatocyte injury. 1,2 Howpatients with chronic hepatitis B after the acquisition ever, with current molecular biological techniques, trace of anti -hepatitis B surface antigen antibodies (anticoncentrations of HBV DN

Prevalence of isolated antibody to hepat
✍ Anna S. F. Lok; Ching-Lung Lai; Pui-Chee Wu πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 622 KB

Of 1,801 Chinese subjects, age 1 to 90 years, screened for hepatitis B surface antigen and antibody (HBsAg, anti-HBs) and antibody to hepatitis B core antigen (anti-HBc), 214 (1 1.9%) had an isolated, positive anti-HBc result; anti-HBc was reproducibly present in the initial sera in only 66% and per

PreS deletion mutations of hepatitis B v
✍ Xiangyan Huang; Yanghua Qin; Peng Zhang; Gusheng Tang; Qingfen Shi; Jun Xu; Fali πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 232 KB πŸ‘ 2 views

Hepatitis B surface antigen (HBsAg) and anti-HBs antibodies (anti-HBs) may coexist in certain chronic hepatitis B (CHB) patients. This study was designed to further explore the relationship between this coexistence and hepatitis B Virus (HBV) preS deletions. Sera of 28 patients carrying both HBsAg a

Comprehensive analysis of the prevalence
✍ Qiang Ma; Yefu Wang πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

## Abstract Escape mutations in the major hydrophilic region (MHR) of hepatitis B surface antigen (HBsAg) are reported widely worldwide; these mutations lead to diagnostic problems, emergence of vaccine‐escape mutants, and hepatitis B immunoglobulin (HBIG) therapy failure. However, the prevalence o